Related Experiment Video
Updated: Jul 8, 2026
05:39
Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
Published on: July 8, 2020
Spatial transcriptomic profiling reveals molecular signatures of endocapillary hypercellularity in IgA nephropathy
Hyeon Do Jeon1, Kyung Hwan Jeong2, Hyeon Seok Hwang2
1Department of Precision Medicine, College of Medicine, Kyung Hee University, Seoul, 02447, South Korea.
BMC Nephrology
|July 7, 2026
Summary
This study reveals molecular signatures of endocapillary hypercellularity in Immunoglobulin A nephropathy (IgAN), identifying key gene changes and pathways. These findings offer potential biomarkers for disease activity and therapeutic targets in IgAN patients.
Area of Science:
- Nephrology
- Molecular Biology
- Genomics
Background:
- Immunoglobulin A nephropathy (IgAN) is a primary cause of chronic kidney disease.
- Endocapillary hypercellularity (E0/E1) in IgAN correlates with disease severity but its molecular basis is unknown.
Purpose of the Study:
- To investigate the molecular mechanisms underlying endocapillary hypercellularity in IgAN.
- To identify gene expression differences in IgAN kidney biopsies with varying degrees of endocapillary hypercellularity.
Main Methods:
- Spatial transcriptomics (GeoMx DSP) analyzed kidney biopsy specimens from East Asian patients.
- Differential gene expression analysis and pathway enrichment were performed comparing normal, E0, and E1 groups.
Main Results:
- Significant differentially expressed genes (DEGs) were found between normal, E0, and E1 groups, with E1 showing the most changes.
- Novel downregulation of amyloid beta precursor protein, CD47, and integrin alpha V observed in E1 lesions.
- Key pathways identified include ion response and MAPK/ERK signaling, involving genes like DUSP1, EGR1, and FOS.
Conclusions:
- This study elucidates molecular changes associated with endocapillary hypercellularity in IgAN progression.
- Identified gene signatures and pathways may serve as novel biomarkers for IgAN activity.
- These findings suggest potential new therapeutic targets for IgAN treatment.
